Vol 7, No 2 (April 29, 2018): Chinese Clinical Oncology (Cancer Immunotherapy)

Preface

Cancer immunotherapy—the end of the beginning

Han Chong Toh

PDF Pages: 12 Full Text (2654) Open Access

Review Article

What is the role of immunotherapy in breast cancer

Tira J. Tan, Jack J. Chan, Sulastri Kamis, Rebecca Alexandra Dent

PDF Pages: 13 Full Text (11683) Open Access

Emerging role of immunotherapy for childhood cancers

Rupert Handgretinger, Patrick Schlegel

PDF Pages: 14 Full Text (8481) Open Access

Combinatorial strategies of radiotherapy and immunotherapy in nasopharyngeal carcinoma

Eugenia L. L. Yeo, You Quan Li, Khee-Chee Soo, Joseph T. S. Wee, Melvin L. K. Chua

PDF Pages: 15 Full Text (7959) Open Access

The emerging role of oncolytic virus therapy against cancer

Luke Russell, Kah-Whye Peng

PDF Pages: 16 Full Text (18813) Open Access

The evolving role of immune oncology in colorectal cancer

Shaheenah Dawood

PDF Pages: 17 Full Text (4259) Open Access

Editorial

Onward and upward for immuno-oncology

Malcolm K. Brenner

PDF Pages: 18 Full Text (2383) Open Access

Perspective

Immunoregulatory antigens—novel targets for cancer immunotherapy

Ayako Wakatsuki Pedersen, Katharina L. Kopp, Mads Hald Andersen, Mai-Britt Zocca

PDF Pages: 19 Full Text (5788) Open Access

Developing academic cancer immunotherapy in Asia—lessons, challenges, and a vision for Thailand

Nattiya Hirankarn

PDF Pages: 20 Full Text (3021) Open Access

Chimeric antigen receptor T cells, a savior with a high price

Gilberto de Lima Lopes, George R. Nahas

PDF Pages: 21 Full Text (4043) Open Access

Disclosure:

The focused issue “Cancer Immunotherapy” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Han Chong Toh served as the unpaid Guest Editor for the focused issue.